| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 7, 2169-2175, Copyright © 1996 by American Society of Nephrology
REGULAR ARTICLES |
JM Soucie and WM McClellan
Department of Epidemiology, Emory University School of Public Health, Atlanta, GA, USA.
Patients who die within the first 90 days after beginning dialysis are not included in mortality rates and may be absent from incidence counts. To identify factors associated with mortality within 3 months of the initiation of dialysis for ESRD and to estimate the impact of early deaths on ESRD incidence and mortality rates, this study investigated 15,245 patients who began dialysis in Georgia, North Carolina, and South Carolina over a 5-yr period. Data were collected by dialysis facility staff and reported to an ESRD registry. Six percent of all new patients died within 90 days of dialysis initiation (32% of all deaths occurring in the first year of treatment). Characteristics independently associated with increased risk of early death included older age, white race, male gender, physical and nutritional impairment, smoking, and the presence of cancer, congestive heart failure, clinical depression, and history of myocardial infarction. Depending on race-gender group, age-adjusted mortality rates based on this cohort were underestimated by 3 to 12% when patients who died early were excluded. These results suggest that certain patient characteristics-some potentially modifiable-confer increased risk of early death, and that the systematic exclusion of patients who die early from the U.S. national registry substantially influences ESRD mortality rates.
This article has been cited by other articles:
![]() |
O. M. Gutierrez, H. Tamez, I. Bhan, J. Zazra, M. Tonelli, M. Wolf, J. L. Januzzi, Y. Chang, and R. Thadhani N-terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Concentrations in Hemodialysis Patients: Prognostic Value of Baseline and Follow-up Measurements Clin. Chem., August 1, 2008; 54(8): 1339 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Wingard, L. B. Pupim, M. Krishnan, A. Shintani, T. A. Ikizler, and R. M. Hakim Early Intervention Improves Mortality and Hospitalization Rates in Incident Hemodialysis Patients: RightStart Program Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1170 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Garcia-Garcia, G. Briseno-Renteria, V. H. Luquin-Arellan, Z. Gao, J. Gill, and M. Tonelli Survival among Patients with Kidney Failure in Jalisco, Mexico J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1922 - 1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Bradbury, R. B. Fissell, J. M. Albert, M. S. Anthony, C. W. Critchlow, R. L. Pisoni, F. K. Port, and B. W. Gillespie Predictors of Early Mortality among Incident US Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 89 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Amaral, W. Hwang, B. Fivush, A. Neu, D. Frankenfield, and S. Furth Association of Mortality and Hospitalization with Achievement of Adult Hemoglobin Targets in Adolescents Maintained on Hemodialysis J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2878 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. M. Cano, D. Fouque, and X. M. Leverve Application of Branched-Chain Amino Acids in Human Pathological States: Renal Failure J. Nutr., January 1, 2006; 136(1): 299S - 307S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Chandna, E. Kulinskaya, and K. Farrington A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2130 - 2138. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Plantinga, B. G. Jaar, N. E. Fink, J. H. Sadler, N. W. Levin, J. Coresh, M. J. Klag, and N. R. Powe Frequency of patient-physician contact in chronic kidney disease care and achievement of clinical performance targets Int. J. Qual. Health Care, April 1, 2005; 17(2): 115 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Plantinga, N. E. Fink, B. G. Jaar, J. H. Sadler, J. Coresh, M. J. Klag, A. S. Levey, and N. R. Powe Frequency of Sit-Down Patient Care Rounds, Attainment of Clinical Performance Targets, Hospitalization, and Mortality in Hemodialysis Patients J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3144 - 3153. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ejerblad, C. M. Fored, P. Lindblad, J. Fryzek, P. W. Dickman, C.-G. Elinder, J. K. McLaughlin, and O. Nyren Association between Smoking and Chronic Renal Failure in a Nationwide Population-Based Case-Control Study J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2178 - 2185. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Block, P. S. Klassen, J. M. Lazarus, N. Ofsthun, E. G. Lowrie, and G. M. Chertow Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2208 - 2218. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Polkinghorne, S. P. McDonald, R. C. Atkins, and P. G. Kerr Vascular Access and All-Cause Mortality: A Propensity Score Analysis J. Am. Soc. Nephrol., February 1, 2004; 15(2): 477 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chantrel, I. Enache, M. Bouiller, I. Kolb, K. Kunz, P. Petitjean, B. Moulin, and T. Hannedouche Abysmal prognosis of patients with type 2 diabetes entering dialysis Nephrol. Dial. Transplant., January 1, 1999; 14(1): 129 - 136. [Abstract] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673